Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient

Nobuhiko Omori, Hisashi Narai, Tomotaka Tanaka, Shinichiro Tanaka, Ichiro Yamadori, Koichi Ichimura, Tadashi Yoshino, Koji Abe, Yasuhiro Manabe

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A 31-year-old male, who had received a cadaveric renal allograft in April 2003, consulted a clinic for a transient hemiplegia in August 2004. At that time, a course observation without medication was chosen. In October 2004, he was admitted to our hospital by ambulance with a clonic seizure and a recurrence of hemiplegia on the right side of his body. Head magnetic resonance imaging (MRI) showed enhanced multifocal nodular lesions with remarkable cerebral edema mainly in the left frontal lobe. A stereotactic brain biopsy was performed, and the pathological diagnosis was nasal type extranodal T/NK cell lymphoma manifested as the post transplant lymphoproliferative disease (PTLD). Systemic staging workups showed no extra-CNS involvement. Because of his renal dysfunction and no sign of any extra-CNS involvement, a reduction of the immunosuppressants and whole brain radiation therapy (WBRT) (40 Gy) without chemotherapy were applied to his therapeutic regimen. After WBRT, MRI showed a remarkable reduction in the number and size of the tumors, and no neurological abnormalities were physically observed. As of December 2006, no sign of recurrence has subsequently been found in both the intra- and extra-CNS.

Original languageEnglish
Pages (from-to)189-191
Number of pages3
JournalJournal of Neuro-Oncology
Volume87
Issue number2
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Lymphoproliferative Disorders
Human Herpesvirus 4
Natural Killer Cells
Lymphoma
Hemiplegia
Central Nervous System
Transplantation
Kidney
Extranodal NK-T-Cell Lymphoma
Brain
Radiotherapy
Magnetic Resonance Imaging
Recurrence
Ambulances
Brain Edema
Frontal Lobe
Immunosuppressive Agents
Allografts
Seizures
Head

Keywords

  • CNS
  • Nasal T/NK cell lymphoma
  • PTLD
  • Renal transplantation

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient. / Omori, Nobuhiko; Narai, Hisashi; Tanaka, Tomotaka; Tanaka, Shinichiro; Yamadori, Ichiro; Ichimura, Koichi; Yoshino, Tadashi; Abe, Koji; Manabe, Yasuhiro.

In: Journal of Neuro-Oncology, Vol. 87, No. 2, 04.2008, p. 189-191.

Research output: Contribution to journalArticle

Omori, Nobuhiko ; Narai, Hisashi ; Tanaka, Tomotaka ; Tanaka, Shinichiro ; Yamadori, Ichiro ; Ichimura, Koichi ; Yoshino, Tadashi ; Abe, Koji ; Manabe, Yasuhiro. / Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient. In: Journal of Neuro-Oncology. 2008 ; Vol. 87, No. 2. pp. 189-191.
@article{72b41714d348411ebeab164008ce601f,
title = "Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient",
abstract = "A 31-year-old male, who had received a cadaveric renal allograft in April 2003, consulted a clinic for a transient hemiplegia in August 2004. At that time, a course observation without medication was chosen. In October 2004, he was admitted to our hospital by ambulance with a clonic seizure and a recurrence of hemiplegia on the right side of his body. Head magnetic resonance imaging (MRI) showed enhanced multifocal nodular lesions with remarkable cerebral edema mainly in the left frontal lobe. A stereotactic brain biopsy was performed, and the pathological diagnosis was nasal type extranodal T/NK cell lymphoma manifested as the post transplant lymphoproliferative disease (PTLD). Systemic staging workups showed no extra-CNS involvement. Because of his renal dysfunction and no sign of any extra-CNS involvement, a reduction of the immunosuppressants and whole brain radiation therapy (WBRT) (40 Gy) without chemotherapy were applied to his therapeutic regimen. After WBRT, MRI showed a remarkable reduction in the number and size of the tumors, and no neurological abnormalities were physically observed. As of December 2006, no sign of recurrence has subsequently been found in both the intra- and extra-CNS.",
keywords = "CNS, Nasal T/NK cell lymphoma, PTLD, Renal transplantation",
author = "Nobuhiko Omori and Hisashi Narai and Tomotaka Tanaka and Shinichiro Tanaka and Ichiro Yamadori and Koichi Ichimura and Tadashi Yoshino and Koji Abe and Yasuhiro Manabe",
year = "2008",
month = "4",
doi = "10.1007/s11060-007-9504-2",
language = "English",
volume = "87",
pages = "189--191",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Epstein-Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient

AU - Omori, Nobuhiko

AU - Narai, Hisashi

AU - Tanaka, Tomotaka

AU - Tanaka, Shinichiro

AU - Yamadori, Ichiro

AU - Ichimura, Koichi

AU - Yoshino, Tadashi

AU - Abe, Koji

AU - Manabe, Yasuhiro

PY - 2008/4

Y1 - 2008/4

N2 - A 31-year-old male, who had received a cadaveric renal allograft in April 2003, consulted a clinic for a transient hemiplegia in August 2004. At that time, a course observation without medication was chosen. In October 2004, he was admitted to our hospital by ambulance with a clonic seizure and a recurrence of hemiplegia on the right side of his body. Head magnetic resonance imaging (MRI) showed enhanced multifocal nodular lesions with remarkable cerebral edema mainly in the left frontal lobe. A stereotactic brain biopsy was performed, and the pathological diagnosis was nasal type extranodal T/NK cell lymphoma manifested as the post transplant lymphoproliferative disease (PTLD). Systemic staging workups showed no extra-CNS involvement. Because of his renal dysfunction and no sign of any extra-CNS involvement, a reduction of the immunosuppressants and whole brain radiation therapy (WBRT) (40 Gy) without chemotherapy were applied to his therapeutic regimen. After WBRT, MRI showed a remarkable reduction in the number and size of the tumors, and no neurological abnormalities were physically observed. As of December 2006, no sign of recurrence has subsequently been found in both the intra- and extra-CNS.

AB - A 31-year-old male, who had received a cadaveric renal allograft in April 2003, consulted a clinic for a transient hemiplegia in August 2004. At that time, a course observation without medication was chosen. In October 2004, he was admitted to our hospital by ambulance with a clonic seizure and a recurrence of hemiplegia on the right side of his body. Head magnetic resonance imaging (MRI) showed enhanced multifocal nodular lesions with remarkable cerebral edema mainly in the left frontal lobe. A stereotactic brain biopsy was performed, and the pathological diagnosis was nasal type extranodal T/NK cell lymphoma manifested as the post transplant lymphoproliferative disease (PTLD). Systemic staging workups showed no extra-CNS involvement. Because of his renal dysfunction and no sign of any extra-CNS involvement, a reduction of the immunosuppressants and whole brain radiation therapy (WBRT) (40 Gy) without chemotherapy were applied to his therapeutic regimen. After WBRT, MRI showed a remarkable reduction in the number and size of the tumors, and no neurological abnormalities were physically observed. As of December 2006, no sign of recurrence has subsequently been found in both the intra- and extra-CNS.

KW - CNS

KW - Nasal T/NK cell lymphoma

KW - PTLD

KW - Renal transplantation

UR - http://www.scopus.com/inward/record.url?scp=41549155688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549155688&partnerID=8YFLogxK

U2 - 10.1007/s11060-007-9504-2

DO - 10.1007/s11060-007-9504-2

M3 - Article

VL - 87

SP - 189

EP - 191

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -